mTOR inhibitors: A novel class of anti-cancer agents

被引：5
|
作者：
Riaz, Haris [1 ,2 ]
Riaz, Talha [1 ]
Hussain, Syed A. [3 ]
机构：
[1] Dow Univ Hlth Sci, Karachi, Pakistan
[2] Civil Hosp, Karachi, Pakistan
[3] Dow Med Coll, Karachi, Pakistan
来源：
INFECTIOUS AGENTS AND CANCER | 2012年 / 7卷
关键词：
MAMMALIAN TARGET;
D O I：
10.1186/1750-9378-7-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Novel N-hydroxybenzamide histone deacetylase inhibitors as potential anti-cancer agents
    Jiao, Jie
    Fang, Hao
    Xu, Wenfang
    DRUG DISCOVERIES AND THERAPEUTICS, 2008, 2 (04): : 211 - 215
  • [22] Design, synthesis, and biological evaluation of novel histone deacetylase inhibitors as anti-cancer agents
    Al-Hamashi, Ayad
    Tillekeratne, L. M. Viranga
    Dlamini, Samikeliso
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [23] An efficient protocol for the synthesis of β-substituted ethyl dithiocarbamates: A novel class of anti-cancer agents
    Chaturvedi, Devdutt
    Zaidi, Sadaf
    Chaturvedi, Amit K.
    Vaid, Shagun
    Saxena, Ajit K.
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2016, 55 (08): : 1019 - 1025
  • [24] Design, Synthesis and Biological Evaluation of Novel Rapamycin Benzothiazole Hybrids as mTOR Targeted Anti-cancer Agents
    Xie, Lijun
    Huang, Jie
    Chen, Xiaoming
    Yu, Hui
    Li, Kualiang
    Yang, Dan
    Chen, Xiaqin
    Ying, Jiayin
    Pan, Fusheng
    Lv, Youbing
    Cheng, Yuanrong
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 64 (04) : 346 - 355
  • [25] The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents
    Sankhala, Kamalesh
    Mita, Alain
    Kelly, Kevin
    Mahalingam, Devalingam
    Giles, Francis
    Mita, Monica
    TARGETED ONCOLOGY, 2009, 4 (02) : 135 - 142
  • [26] The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents
    Kamalesh Sankhala
    Alain Mita
    Kevin Kelly
    Devalingam Mahalingam
    Francis Giles
    Monica Mita
    Targeted Oncology, 2009, 4 : 135 - 142
  • [27] Progress on kinesin spindle protein inhibitors as anti-cancer agents
    Zhang, Yingjie
    Xu, Wenfang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2008, 8 (06) : 698 - 704
  • [28] Recent progress in the identification of BRAF inhibitors as anti-cancer agents
    El-Nassan, Hala Bakr
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 72 : 170 - 205
  • [29] Recent Developments of Steroid Sulfatase Inhibitors as Anti-Cancer Agents
    Foster, Paul A.
    Reed, Michael J.
    Purohit, Atul
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2008, 8 (07) : 732 - 738
  • [30] Achieving clinical success with BET inhibitors as anti-cancer agents
    Shorstova, Tatiana
    Foulkes, William D.
    Witcher, Michael
    BRITISH JOURNAL OF CANCER, 2021, 124 (09) : 1478 - 1490
12345